TANDEM FC BISPECIFIC ANTIBODIES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14185628

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are tandem Fcs and tandem Fc antibodies (“TFcAs”), e.g., tandem Fc bispecific antibodies (“TFcBAs”), which comprise one or at least two binding sites that specifically bind to one or more cell surface receptors. The binding sites are connected through a TFc, which TFc comprises a first Fc region and a second Fc region, wherein the first and the second Fc regions are linked through a TFc linker to form a contiguous polypeptide and dimerize to form an Fc dimer. Exemplary TFcBAs inhibit signal transduction through the cell surface receptor(s) for which the binding sites of the TFcBA are specific.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERRIMACK PHARMACEUTICALS INCONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
GEDDIE, Melissa Somerville, US 11 19
HARMS, Brian Roslindale, US 44 638
KOHLI, Neeraj Brighton, US 35 225
LUGOVSKOY, Alexey Woburn, US 30 247
SU, Stephen Boston, US 13 88

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation